Clinical Trial Update: EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes

View source ↗

Summary

The EXPLAIN - Fragile X Registry is an exploratory, longitudinal study on Fragile X syndrome that has been terminated according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Fragile-X Syndrome | Status: TERMINATED